Kodiak Sciences Inc. financial data

Symbol
KOD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1200 Page Mill Rd, Palo Alto, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Oligasis, LLC (to 7/28/2009)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 704 % -0.5%
Debt-to-equity 82 % +38.6%
Return On Equity -77.2 % -6.53%
Return On Assets -42.4 % +6.85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.6M shares +0.31%
Common Stock, Shares, Outstanding 52.6M shares +0.31%
Entity Public Float 222M USD -8.33%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 52.6M shares +0.34%
Weighted Average Number of Shares Outstanding, Diluted 52.6M shares +0.34%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 145M USD -39.8%
General and Administrative Expense 66.7M USD -7.22%
Operating Income (Loss) -212M USD +32.3%
Net Income (Loss) Attributable to Parent -198M USD +33.8%
Earnings Per Share, Basic -3.77 USD/shares +33.9%
Earnings Per Share, Diluted -3.77 USD/shares +33.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 219M USD -42.1%
Marketable Securities, Current 0 USD -100%
Assets, Current 225M USD -42%
Property, Plant and Equipment, Net 111M USD -14.4%
Operating Lease, Right-of-Use Asset 50.6M USD -11.7%
Other Assets, Noncurrent 8.86M USD -1.64%
Assets 402M USD -31.9%
Accounts Payable, Current 1.87M USD -84.8%
Employee-related Liabilities, Current 3.94M USD -9.12%
Accrued Liabilities, Current 9.44M USD -82.5%
Liabilities, Current 21.2M USD -71.4%
Operating Lease, Liability, Noncurrent 65.9M USD -14.4%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 187M USD -25.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.24B USD -19%
Stockholders' Equity Attributable to Parent 215M USD -36.6%
Liabilities and Equity 402M USD -31.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.6M USD +16.1%
Net Cash Provided by (Used in) Financing Activities 38K USD
Net Cash Provided by (Used in) Investing Activities -166K USD -100%
Common Stock, Shares Authorized 490M shares 0%
Common Stock, Shares, Issued 52.6M shares +0.31%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 373M USD +7.39%
Deferred Tax Assets, Gross 386M USD +5.03%
Operating Lease, Liability 81.6M USD -6.95%
Depreciation 4.7M USD +23.4%
Payments to Acquire Property, Plant, and Equipment 22K USD -99.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -198M USD +33.3%
Lessee, Operating Lease, Liability, to be Paid 105M USD -10.6%
Property, Plant and Equipment, Gross 143M USD +127%
Operating Lease, Liability, Current 9.89M USD +25.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.3M USD +8.64%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8M USD -5.16%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23.3M USD -16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.6M USD +7.17%
Deferred Tax Assets, Operating Loss Carryforwards 134M USD +14.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.25M USD +8.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.84M USD -38.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 12.2M USD -37.2%
Share-based Payment Arrangement, Expense 73.6M USD -29.1%
Interest Expense 5K USD -68.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%